批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
| 提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级；罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
|---|
| 2016/01/13 |
SUPPL-11（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2008/07/07 |
SUPPL-10（补充） |
Approval |
Labeling |
STANDARD
|
|
|
| 2007/08/21 |
SUPPL-4（补充） |
Approval |
Labeling |
STANDARD
|
|
|
| 2007/08/21 |
SUPPL-3（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2004/10/18 |
SUPPL-9（补充） |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/10/18 |
SUPPL-8（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2002/03/08 |
SUPPL-2（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2000/07/18 |
SUPPL-1（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1999/12/08 |
ORIG-1（原始申请） |
Approval |
Type 3 - New Dosage Form |
PRIORITY
|
|
|
与本品相关的专利信息（来自FDA橙皮书Orange Book）
与本品治疗等效的药品
活性成分:NEDOCROMIL SODIUM 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AT
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
|---|
| 021009 |
001 |
NDA |
ALOCRIL |
NEDOCROMIL SODIUM |
SOLUTION/DROPS;OPHTHALMIC |
2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Discontinued |
Yes |
No |
AT |
1999/12/08
|
ALLERGAN |
